P
P. Konopasek
Researcher at First Faculty of Medicine, Charles University in Prague
Publications - 6
Citations - 85
P. Konopasek is an academic researcher from First Faculty of Medicine, Charles University in Prague. The author has contributed to research in topics: Retrospective cohort study & Microscopic polyangiitis. The author has an hindex of 3, co-authored 6 publications receiving 74 citations.
Papers
More filters
Journal ArticleDOI
Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study.
Zdenka Hruskova,A L Casian,P. Konopasek,B. Svobodova,Doubravka Frausova,V. Lanska,Vladimir Tesar,D R W Jayne +7 more
TL;DR: Current treatment of severe AH leads to remission but long-term mortality remains high, and Concurrent renal failure and older age were associated with higher mortality.
Journal ArticleDOI
Increased Levels of Soluble ST2 in Patients with Active Newly Diagnosed ANCA-Associated Vasculitis
Z. Hladinova,Zdenka Hruskova,B. Svobodova,Karin Malickova,V. Lanska,P. Konopasek,Eva Jancova,Romana Rysava,Charles L. Edelstein,Vladimir Tesar +9 more
TL;DR: Serum sST2, but not serum IL-33, may be a marker of activity in AAV patients, and these levels were higher in patients with granulomatosis with polyangiitis than in patients in remission.
Journal ArticleDOI
Serum hepcidin is increased in ANCA-associated vasculitis and correlates with activity markers.
TL;DR: Hepcidin concentration was increased in patients with AAV, SLE and HD and correlated positively with C-reactive protein, serum ferritin and creatinine, and negatively with hemoglobin and serum transferrin, and in active form of AAV it correlated with the clinical scoring system (BVAS).
Zánětlivý pseudotumor močového měchýře jako projev aktivity u pacientky s granulomatózou s polyangiitidou (Wegenerovou granulomatózou) - méně obvyklá manifestace ANCA-asociované vaskulitidy
Jakub Řezáč,Zdenka Hruskova,P. Konopasek,Eva Honsová,Martin Masek,Romana Rysava,Vladimír Tesař +6 more
TL;DR: Granulomatoza s polyangiitidou (GPA) as discussed by the authors is a polygonal tumor tumor suppressor that is used for cancer treatment in Ceske republice.
Journal ArticleDOI
Long-term outcome of severe alveolar hemorrhage in ANCA-associated vasculitis: A retrospective cohort study
Zdenka Hruskova,A L Casian,P. Konopasek,B. Svobodova,Doubravka Frausova,V. Lanska,Vladimir Tesar,David Jayne +7 more
TL;DR: All the patients with SVV with sudden deterioration of kidney function, anemia and thrombocytopenia should be suspected to have aHUS and starting an early appropriate treatment with PE or complement blocking agents such as eculizumab could improve patient’s morbidity and mortality.